Physicians Realty Trust
Change company Symbol lookup
Select an option...
DOC Physicians Realty Trust
CYDVF Cypress Development Corp
KEYS Keysight Technologies Inc
HBAN Huntington Bancshares Inc
MMP Magellan Midstream Partners LP
VTI Vanguard Total Stock Market Index Fund ETF Shares
SKX Skechers USA Inc
RMGCW RMG Acquisition Equity III Warrant Exp 08 Feb 2026 *W EXP 02/08/2026
IKNA Ikena Oncology Inc
KRYS Krystal Biotech Inc
Go

Real Estate : Equity Real Estate Investment Trusts (REITs) | Small Cap Blend
Company profile

Physicians Realty Trust (the Trust) is a self-managed real estate investment trust. Physicians Realty L.P. is the operating partnership of the Trust. The Trust and its operating partnership are engaged in acquiring, developing, owning and managing healthcare properties that are leased to physicians, hospitals and healthcare delivery systems. The Trust’s principal investments include medical office buildings, outpatient treatment facilities, as well as other real estates integral to health care providers. The Trust’s properties are located on a campus with a hospital or other health care facilities. The Trust’s portfolio consists of approximately 263 health care properties located in 31 states with approximately 14,080,739 net leasable square feet. The Trust invests in real estate and provides health care services.

Closing Price
$17.97
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
1,774,942
0

SPPI Lawsuit Filed: Jakubowitz Law Pursues Claims on Behalf of Spectrum Pharmaceuticals, Inc. Shareholders

12:30 pm ET October 28, 2021 (Newsfile) Print

New York, New York--(Newsfile Corp. - October 28, 2021) -  Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI).

CLICK HERE FOR MORE DETAILS:

https://claimyourloss.com/securities/spectrum-pharmaceuticals-inc-loss-submission-form/?id=20745&from=5

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/7135/101172_245906_logo.jpg

Affected shareholders purchased shares of SPPI between December 27, 2018 and August 5, 2021

Shareholders interested in representing the class of wronged shareholders have until November 1, 2021 to petition the court. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

According to a filed complaint, Spectrum Pharmaceuticals, Inc. issued materially false and/or misleading statements and/or failed to disclose that: (i) the manufacturing facility for ROLONTIS, an investigational granulocyte-colony stimulating factor analog, maintained deficient controls and/or procedures; (ii) the foregoing deficiencies decreased the likelihood that the Food and Drug Administration would approve the ROLONTIS biologics license application ("BLA") in its current form; (iii) Spectrum had therefore materially overstated the ROLONTIS BLA's approval prospects; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.

Jakubowitz Law is vigorous in pursuit of justice for shareholders who have been the victim of securities fraud. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

JAKUBOWITZ LAW

1140 Avenue of the Americas

9th Floor

New York, New York 10036

T: (212) 867-4490

F: (212) 537-5887

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/101172

comtex tracking

COMTEX_395965212/2523/2021-10-28T12:30:57

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.